Clinical trials: Renal Neoplasma, open to volunteers
Renal Neoplasma
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal…
- Trial name
- NCT02487550
- Testing
- DC-CIK, IL-2/IFN-α
- Volunteers
- 1,200 people
- Sponsor
- The First People's Hospital of Changzhou